A detailed history of Vanguard Group Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,471,247 shares of HRMY stock, worth $118 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,471,247
Previous 3,519,387 1.37%
Holding current value
$118 Million
Previous $106 Million 30.61%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.0 - $39.95 $1.44 Million - $1.92 Million
-48,140 Reduced 1.37%
3,471,247 $139 Million
Q2 2024

Aug 13, 2024

SELL
$28.81 - $33.01 $3.14 Million - $3.59 Million
-108,838 Reduced 3.0%
3,519,387 $106 Million
Q1 2024

May 10, 2024

SELL
$29.93 - $35.06 $1.39 Million - $1.63 Million
-46,539 Reduced 1.27%
3,628,225 $122 Million
Q4 2023

Feb 14, 2024

SELL
$19.2 - $33.78 $180,249 - $317,126
-9,388 Reduced 0.25%
3,674,764 $119 Million
Q3 2023

Nov 14, 2023

BUY
$31.89 - $39.03 $2.82 Million - $3.45 Million
88,295 Added 2.46%
3,684,152 $121 Million
Q2 2023

Aug 14, 2023

BUY
$30.5 - $37.4 $1.85 Million - $2.27 Million
60,572 Added 1.71%
3,595,857 $127 Million
Q1 2023

May 15, 2023

BUY
$30.8 - $53.92 $8.64 Million - $15.1 Million
280,644 Added 8.62%
3,535,285 $115 Million
Q4 2022

Feb 10, 2023

BUY
$45.4 - $60.91 $11.4 Million - $15.3 Million
251,185 Added 8.36%
3,254,641 $179 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $1.64 Million - $2.16 Million
38,958 Added 1.31%
3,003,456 $133 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $52.15 $8.79 Million - $13.7 Million
261,985 Added 9.69%
2,964,498 $145 Million
Q1 2022

May 13, 2022

BUY
$33.14 - $51.13 $1.44 Million - $2.22 Million
43,428 Added 1.63%
2,702,513 $131 Million
Q4 2021

Feb 14, 2022

SELL
$34.09 - $43.91 $15 Million - $19.4 Million
-440,856 Reduced 14.22%
2,659,085 $113 Million
Q3 2021

Nov 12, 2021

BUY
$25.68 - $38.61 $49.8 Million - $74.8 Million
1,938,066 Added 166.81%
3,099,941 $119 Million
Q2 2021

Aug 13, 2021

BUY
$25.96 - $33.44 $30.2 Million - $38.9 Million
1,161,875 New
1,161,875 $32.8 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.